The Drug Enforcement Agency (DEA) has issued two notices of intent to schedule three 7-hydroxymitragynine-related substances and tianeptine.

There is a risk of severe arboviral neuroinvasive disease among patients who are receiving B cell-depleting or B cell-modulating medications, particularly anti-CD20 monoclonal antibodies (mAbs).

The PAMED Board of Trustees met for its hybrid August 7 meeting and reviewed several key updates, appointments, and ongoing strategic initiatives.

On August 11, 2026, the U.S. Fifth Circuit Court of Appeals provided physicians with a win in a lawsuit related to the independent dispute resolution (IDR) process provided for by the federal No Suprises Act (NSA).

To get ready for license renewal, please make sure your contact information is current and accurate in the Pennsylvania Licensing System (PALS).

The Pennsylvania Medical Society (PAMED) strongly supports vaccination and other evidence-based practices and has significant concerns about the Executive Order #14407 signed by President Trump on Monday, August 10, 2026.

The American Medical Association is seeking applications from medical students and physicians with disabilities to serve on the Disability Advisory Group (DAG) for the 2027–2028 term.

The Department of Human Services (Department) announces changes to the Medical Assistance (MA) Program Fee Schedule.

Recently, the FDA approved Tylenol with Naproxen, the first fixed-dose combination product to pair acetaminophen with naproxen sodium in a single combination tablet for up to 12 hours of pain relief.

The Pennsylvania Department of Health confirmed a Snyder County resident tested positive for measles and may have exposed others at the Lowe’s in Selinsgrove (near Sunbury) on July 14.

The Department of Health (Department) is extending the temporary scheduling of Substance; Nitazene Class of Compounds

The PA Department of Human Services (Department) has announced the availability of program payments for certain qualified entities to fully onboard to the Statewide health information exchange, the Pennsylvania Patient and Provider Network (P3N).

The Pennsylvania Department of Health and the Centers for Disease Control and Prevention, are notifying clinicians, public health practitioners, and laboratorians of cases of domestically acquired cyclosporiasis in multiple states, including Pennsylvania.

PAMED submitted comments in response to requests for information issued by the Office of Management and Budget (OMB) on the Notice of Proposed Rulemaking (NPRM) concerning the Uniform Guidance governing federal grants. OMB proposes revisions that would improve transparency, accountability, and oversight for Federal financial assistance including grants.

On July 11, 2026, the Insurance Department (Department) published a list of approved Independent Review Organizations (IRO) and the fees they charge to insurers and Medical Assistance and CHIP Managed Care Organizations for conducting independent external reviews of adverse benefit determinations and grievances.

Following a 12-day impasse, Governor Josh Shapiro signed a bipartisan compromise $50.85 billion state budget for FY 2026-27. The spending plan, passed by the Pennsylvania General Assembly and signed into law on Sunday July 12, increases overall spending by about 3.7% without taking any of the state’s $8 billion Rainy Day Fund and avoiding any new or increased broad-based taxes.

The Pennsylvania Department of Health (DOH) launched a new online dashboard to keep Pennsylvania families and communities informed about measles cases in the Commonwealth, including case details on county, age, and hospitalizations.

The Centers for Disease Control and Prevention (CDC) is notifying clinicians, public health practitioners, and laboratorians of cases of domestically acquired cyclosporiasis in multiple U.S. states.

The Pennsylvania Medical Society (PAMED) is pleased to announce the 2026/27 recipients of its annual Innovation Grant.

Last week, PAMED hosted a webinar highlighting the ongoing work of its Unionization Task Force, presented by Task Force Chair F. Wilson Jackson, III, MD and PAMED Board Chair Lorraine Rosamilia, MD, FAAD.